Biotech Values

[DewDiligence]

Re: OXGN’s Oxi4503:

isolution et al: I find it interesting that CA4 and CA1 differ by only the change of one hydrogen to a hydroxyl on one of the outer carbon rings.
Supposedly, Oxi4503, the pro-drug form of CA1, will do wondrous things to the periphery of tumor masses, which tends to be least affected by VTA’s in general and CA4P in particular. Do you have any comments on the medicinal chemistry that would be understandable to a lay audience? T.i.a.